Comparable stake leader
Rafael Holdings, Inc.
SEC ownership of Cyclo Therapeutics, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0000922247.
Disclosed value leader
Rafael Holdings, Inc.
Comparable rows
0/15
Latest evidence
27 Feb 2025
- Parsed ownership sources
-
3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Rafael Holdings, Inc.
Ranking: Comparable ownership first, then disclosed value
- Latest parsed ownership date
-
27 Feb 2025
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0000922247
- Issuer location
- Gainesville, FL
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
1 signal
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Cyclo Therapeutics, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Rafael Holdings, Inc.
Disclosed value leader
Rafael Holdings, Inc.
Comparable rows
0/15
Latest evidence
27 Feb 2025
3/4/5
Highest disclosed value: $8,188,862
15 rows are not safely comparable across share classes.
Showing 1-8 of 15 holder rows.
Quick read
Rafael Holdings, Inc. has the largest disclosed position value at $8.19M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Rafael Holdings, Inc.'s linked filing trail.
Disclosed position value
Top 5
Rafael Holdings, Inc.
$8.19M
N. Scott Fine
$569.3K
Markus Sieger
$277.4K
Francis Patrick Ostronic
$264K
Ce Rick Strattan
$251.5K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-8 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Rafael Holdings, Inc. |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$8,188,862
12,998,194 shares
|
— | 23 Dec 2024 |
| N. Scott Fine |
3/4/5
Chief Executive Officer, Director
|
—
mixed-class rows
|
$569,269
1,339,500 shares
mixed-class rows
|
— | 03 Jun 2024 |
| Markus Sieger |
3/4/5
Director
|
—
mixed-class rows
|
$277,364
455,822 shares
mixed-class rows
|
— | 27 Feb 2025 |
| Francis Patrick Ostronic |
3/4/5
Director
|
—
mixed-class rows
|
$264,033
434,662 shares
mixed-class rows
|
— | 27 Feb 2025 |
| Ce Rick Strattan |
3/4/5
Director
|
—
mixed-class rows
|
$251,541
414,834 shares
mixed-class rows
|
— | 27 Feb 2025 |
| Randall M. Toig |
3/4/5
Director
|
—
mixed-class rows
|
$112,856
194,699 shares
mixed-class rows
|
— | 27 Feb 2025 |
| William S. Shanahan |
3/4/5
Director
|
—
mixed-class rows
|
$109,599
189,528 shares
mixed-class rows
|
— | 27 Feb 2025 |
| Shawn Cross |
3/4/5
Director
|
—
mixed-class rows
|
$85,898
151,908 shares
mixed-class rows
|
— | 27 Feb 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 28 Aug 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-15 of 15 reporting-owner rows connected to Cyclo Therapeutics, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
15
Largest Forms 3/4/5 holder
Rafael Holdings, Inc.
Net 12M change
$0
Latest report
27 Feb 2025
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Rafael Holdings, Inc. | 10%+ Owner | $8,188,862 | Mixed | 23 Dec 2024 | ||
| N. Scott Fine | Chief Executive Officer, Director | $569,269 | Mixed | 03 Jun 2024 | ||
| Markus Sieger | Director | $277,364 | Mixed | 27 Feb 2025 | ||
| Francis Patrick Ostronic | Director | $264,033 | Mixed | 27 Feb 2025 | ||
| Ce Rick Strattan | Director | $251,541 | Mixed | 27 Feb 2025 | ||
| Randall M. Toig | Director | $112,856 | Mixed | 27 Feb 2025 | ||
| William S. Shanahan | Director | $109,599 | Mixed | 27 Feb 2025 | ||
| Shawn Cross | Director | $85,898 | Mixed | 27 Feb 2025 | ||
| Jeffrey Tate | Chief Operating Officer, Director | $69,467 | Mixed | 03 Jun 2024 | ||
| William Conkling | Director | $49,067 | Mixed | 27 Feb 2025 | ||
| Vivien Wong | Director | $40,857 | Mixed | 27 Feb 2025 | ||
| Sharon Hemond Hrynkow | Chief Scientific Officer | $13,739 | Mixed | 02 Dec 2021 | ||
| Lise Lund Kjems | Chief Medical Officer | Mixed | 07 Mar 2023 | |||
| Joshua M. Fine | Chief Financial Officer | Mixed | 03 Jun 2024 | |||
| Michael Eric Lisjak | Chief Regulatory Officer | Mixed | 03 Jun 2024 |
Recent insider transactions for Cyclo Therapeutics, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* marks a reported price that did not pass the local price check.